BridgeMD
Tests treatment safety and results for Stroke
Official title Clinical and Ultrasonographic Evaluation of the Efficacy of Extracorporeal Shock Wave Therapy (ESWT) in Post-Stroke Spasticity
ClinicalTrials.gov ID: NCT07119801
What this study is testing
- What it's testing
- This research evaluate the effectiveness of Extracorporeal Shock Wave Therapy (ESWT) for treating spasticity in the wrist flexor muscles (flexor carpi ulnaris - FCU and flexor carpi radialis - FCR) of chronic stroke patients. Spasticity, a common complication after a stroke, causes muscle stiffness, pain, and functional limitation, leading to increased healthcare costs and a lower quality of life.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 35 to 65
You may be able to join if
- Age between 35 and 65 years.
- First-ever stroke episode confirmed by MRI and/or CT scan.
- Clinical diagnosis of hemiplegia.
- More than 6 months post-stroke.
- A Modified Ashworth Scale (MAS) score between 1 and 3 for wrist flexor spasticity.
You likely can't join if
- History of more than one stroke episode
- Stroke onset more than ten years ago
- Stroke onset less than 6 months ago
- Age over 65 (to limit the effects of aging on muscle structure)
- Contraindications for ESWT (e.g., cancer, local tumor or active infection in the treatment area, pregnancy, coagulation disorders, pacemaker or other...
- Severe aphasia or serious communication problems
See the full eligibility criteria
- Age between 35 and 65 years.
- First-ever stroke episode confirmed by MRI and/or CT scan.
- Clinical diagnosis of hemiplegia.
- More than 6 months post-stroke.
- A Modified Ashworth Scale (MAS) score between 1 and 3 for wrist flexor spasticity.
- History of more than one stroke episode
- Stroke onset more than ten years ago
- Stroke onset less than 6 months ago
- Age over 65 (to limit the effects of aging on muscle structure)
- Contraindications for ESWT (e.g., cancer, local tumor or active infection in the treatment area, pregnancy, coagulation disorders, pacemaker or other electronic/metallic implants)
- Severe aphasia or serious communication problems
- Presence of fixed contracture in the wrist
- Patients who have received botulinum toxin or phenol nerve block injections within the last 6 months
- Medically unstable patients (e.g., uncontrolled hypertension, diabetes mellitus, or severe cardiac, hepatic, or renal disease)
The study team makes the final eligibility decision.
Where it's taking place
- Denizli, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 35 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Denizli, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.